FindTrial
Sign In

Retrospective analysis of medullary thyroid carcinoma patients visiting at Department of Endocrinology.

Retrospective analysis of medullary thyroid carcinoma patients visiting at Department of Endocrinology at a tertiary care hospital.

Status
Active, not recruiting
Phases
Unknown
Study type
Observational
Source
CTRI
Registry ID
CTRI/2019/12/022382
Enrollment
70
Registered
2019-12-16
Start date
Unknown
Completion date
Unknown
Last updated
2021-11-24

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

Health Condition 1: C73- Malignant neoplasm of thyroid gland

Interventions

None listed

Sponsors

Department of Endocrinology
Lead Sponsor

Eligibility

Inclusion criteria

Inclusion criteria: Patients with Medullary thyroid carcinoma (FNAC or histological diagnosis / and or serum calcitonin >100 pg/ml) visiting Dept since January 2008 to August 2019.

Exclusion criteria

Exclusion criteria: NA

Design outcomes

Primary

MeasureTime frame
disease progression in accordance to calcitonin doubling time.Timepoint: disease progression in accordance to calcitonin doubling time.—

Secondary

MeasureTime frame
NilTimepoint: Nil—

Countries

India

Contacts

Public ContactDr Tushar Ramkrishna Bandgar

Seth G S Medical College and KEM Hospital

drtusharb@gmail.com9820025037

Outcome results

None listed

Source: CTRI (via WHO ICTRP) · Data processed: Feb 4, 2026